September 27, 2006– September 29, 2006
The Canyons Grand Summit Resort Hotel & Conference Center
Park City, Utah
Program Agenda
Wednesday, September 27, 2006
3:00 - 3:15 PM Welcome
Diana Brixner, RPh, PhD
University of Utah
Salt Lake City, Utah
Jim Smeeding, MBA, RPh
JestaRx Group
Dallas, Texas
Medicare and Medicaid
Measuring the Impact of Part-D
on the States – A national and state perspective
5:15 - 6:00 PM Panel Discussion and Q&A
6:30 - 10:00 PM Reception in the Grand Ballroom Lobby
7:00 - 10:00 PM Dinner in Kokopelli - Parlor lll
Thursday, September 28, 2006
7:00 - 8:00 AM Breakfast in the Pavilion
8:00 - 8:10 AM Welcome
Diana Brixner, RPh, PhD
8:10 – 9:00 AM
Defining the Population of Part D: An Actuarial Overview on Benefit Design and Risk
Brian Januzik
Asst VP & Corporate Actuary
Caremark
9:00 - 9:45 AM
Financing and Delivering Health to a Medicaid Population
9:45 - 10:15 AM Panel Q&A
10:30 - 12:30 PM Health Policy Impact on Quality and Care
Michael O’Grady
CMS Quality Panel
12:30 - 1:30 PM Lunch
1:30 - 2:45 PM
Women’s Health Outcomes in Medicaid Contraception and Women’s Health
Jeff McMullough
Other Issues on Women’s Health:
Osteoporosis
Breast Cancer Screening
Pre-natal Care
High Risk Pregnancies
Ilene Zuckerman – Univ. Maryland
Karen Gunning - Family Medicine Univ. of Utah
2:45 – 3:15 PM Panel Q&A
3:15 – 3:30 PM Break
3:30 - 5:30 PM
Where Has All The Data Gone?
Moderator: Joel Hay, USC
6:45 – 10:00 PM Dinner at the Riverhorse
Friday, September 29, 2006
7:00 - 8:00 AM Breakfast in the Pavilion
8:00 – 10:00 AM
Medical Therapy Management, High Cost of Therapies, Populations at Risk
Airways Diseases in High Risk Populations
Phil Sheridan,
Pulmonology Pediatric Asthma
Cardiovascular Research in Medicaid
Fadia Shaya
University of Maryland
Smoking Cessation
COPD
Asthma
10:00 AM – Noon Departure and Box Lunch
We would like to thank all of our sponsors for educational grants in support of the program:
Platinum Sponsors:
Additional Sponsors: Abbott Pharmaceuticals, AstraZeneca,
Boehringer-Ingelheim, Daiichi-Sankyo, Takeda Pharmaceuticals